Compugen Ltd. ( CGEN) - Stock Earnings
CGEN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
CGEN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 56.8 million USD | 67.3 million USD |
| 2026Q1 | -7.7 million USD | 2.2 million USD |
| 2026Q2 | -7.0 million USD | 2.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CGEN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -18.8 million USD | 33.5 million USD |
| 2024 | -14.2 million USD | 27.9 million USD |
| 2025 | 35.3 million USD | 72.8 million USD |
| 2026 Est. | — | — |
CGEN
Price: $2.04
Earnings Per Share: 0.38 USD
P/E Ratio: 6.34
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 1.0 million
Ebitda: -10.0 millionMarket Capitalization: 218.4 million